<DOC>
	<DOCNO>NCT01336296</DOCNO>
	<brief_summary>This study specifically design determine whether initiation Myfortic 2 week prior transplantation enhance therapeutic efficacy Simulect induction therapy low moderate risk patient . Specifically , addition Myfortic pretransplant Simulect induction compare standard Myfortic therapy Thymoglobulin induction start time transplant kidney transplant recipient .</brief_summary>
	<brief_title>Evaluate Effects Safety Pre-load Myfortic® Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Patients capable understanding purpose risk study . Patients give write informed consent , willing able participate full course study . Women childbearing potential must negative serum pregnancy test within last 48 hour prior receive study medication . Women childbearing potential must use two reliable form contraception simultaneously , unless status post bilateral tubal ligation , bilateral oophorectomy , hysterectomy . Effective contraception must use begin study drug therapy , duration study 6 week follow completion study . Patients recipients multiple organ transplant patient previously receive organ transplant . Patients recipient ABO incompatible transplant , complementdependent cytotoxicity ( CDC ) crossmatch positive transplant . Sensitized patient [ recent antiHuman Leukocyte Antigens ( HLA ) Class I panel reactive antibody ( PRA ) ≥ 25 % CDCbased assay ] . Recipient donor know seropositive hepatitis C virus ( HCV ) B virus ( HBV ) except hepatitis B surface antibody positive . Recipient donor know seropositive human immunodeficiency virus ( HIV ) . Patient uncontrolled concomitant infection unstable medical condition could interfere study objective . Patients thrombocytopenia ( &lt; 75,000/mm3 ) , absolute neutrophil count &lt; 1,500/mm3 ) ; and/or leucopoenia ( &lt; 2,500/mm3 ) , anemia ( hemoglobin &lt; 6 g/dL ) prior study inclusion . Patient take take investigational drug 30 day prior transplant . Patient known hypersensitivity tacrolimus , mycophenolate mofetil , entericcoated mycophenolic acid , rabbit antithymocyte globulin , corticosteroid . Patients severe diarrhea gastrointestinal disorder might interfere ability absorb oral medication ; diabetic patient previously diagnose diabetic gastroenteropathy , patient active peptic ulcer disease . Patient receive chronic steroid therapy time transplant . Patients history malignancy within last five year , except successfully excise squamous basal cell carcinoma skin . Patient pregnant lactating , pregnancy define state female conception termination gestation , confirm positive human Chorionic Gonadotropin ( hCG ) laboratory test . Patient form substance abuse , psychiatric disorder condition , opinion investigator , may invalidate communication investigator . Inability cooperate communicate investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>